Barrett's esophagus: The pathomorphological and molecular genetic keystones of neoplastic progression

被引:8
|
作者
Maslyonkina, Ksenia S. [1 ]
Konyukova, Alexandra K. [1 ]
Alexeeva, Darya Y. [1 ]
Sinelnikov, Mikhail Y. [1 ]
Mikhaleva, Liudmila M. [1 ]
机构
[1] Res Inst Human Morphol, Tzurupi 3, Moscow, Russia
来源
CANCER MEDICINE | 2022年 / 11卷 / 02期
关键词
Barrett's esophagus; epigenetic changes; esophageal cancer; molecular pathways; oncotransformation; preventative targets; HIGH-GRADE DYSPLASIA; CONFOCAL LASER ENDOMICROSCOPY; ACETIC-ACID CHROMOENDOSCOPY; COMPUTER-ASSISTED ANALYSIS; COLUMNAR-LINED ESOPHAGUS; COENZYME-A RACEMASE; INTESTINAL METAPLASIA; MALIGNANT PROGRESSION; INTEROBSERVER AGREEMENT; PREDICTS PROGRESSION;
D O I
10.1002/cam4.4447
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Barrett's esophagus is a widespread chronically progressing disease of heterogeneous nature. A life threatening complication of this condition is neoplastic transformation, which is often overlooked due to lack of standardized approaches in diagnosis, preventative measures and treatment. In this essay, we aim to stratify existing data to show specific associations between neoplastic transformation and the underlying processes which predate cancerous transition. We discuss pathomorphological, genetic, epigenetic, molecular and immunohistochemical methods related to neoplasia detection on the basis of Barrett's esophagus. Our review sheds light on pathways of such neoplastic progression in the distal esophagus, providing valuable insight into progression assessment, preventative targets and treatment modalities. Our results suggest that molecular, genetic and epigenetic alterations in the esophagus arise earlier than cancerous transformation, meaning the discussed targets can help form preventative strategies in at-risk patient groups.
引用
收藏
页码:447 / 478
页数:32
相关论文
共 50 条
  • [21] High-fidelity DNA histograms in neoplastic progression in Barrett's esophagus
    Yu, Chenggong
    Zhang, Xiaoqi
    Huang, Qin
    Klein, Michael
    Goyal, Raj K.
    [J]. LABORATORY INVESTIGATION, 2007, 87 (05) : 466 - 472
  • [22] Neutrophil to lymphocyte ratio and risk of neoplastic progression in patients with Barrett's esophagus
    Peleg, Noam
    Schmilovitz-Weiss, Hemda
    Shamah, Steven
    Schwartz, Ariel
    Dotan, Iris
    Sapoznikov, Boris
    [J]. ENDOSCOPY, 2021, 53 (08) : 774 - 781
  • [23] Predictors for Neoplastic Progression in Patients With Barrett's Esophagus: A Prospective Cohort Study
    Sikkema, M.
    Looman, C. W. N.
    Steyerberg, E. W.
    Kerkhof, M.
    Kastelein, F.
    van Dekken, H.
    van Vuuren, A. J.
    Bode, W. A.
    van der Valk, H.
    Ouwendijk, R. J. T.
    Giard, R.
    Lesterhuis, W.
    Heinhuis, R.
    Klinkenberg, E. C.
    Meijer, G. A.
    ter Borg, F.
    Arends, J. W.
    Kolkman, J. J.
    van Baarlen, J.
    de Vries, R. A.
    Mulder, A. H.
    van Tilburg, A. J. P.
    Offerhaus, G. J. A.
    ten Kate, F. J. W.
    Kusters, J. G.
    Kuipers, E. J.
    Siersema, P. D.
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2011, 106 (07): : 1231 - 1238
  • [24] Mutagen sensitivity and neoplastic progression in patients with Barrett's esophagus: A prospective analysis
    Chao, Dennis L.
    Maley, Carlo C.
    Wu, Xifeng
    Farrow, Diana C.
    Galipeau, Patricia C.
    Sanchez, Carissa A.
    Paulson, Thomas G.
    Rabinovitch, Peter S.
    Reid, Brian J.
    Spitz, Margaret R.
    Vaughan, Thomas L.
    [J]. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2006, 15 (10) : 1935 - 1940
  • [25] Alterations of the Wnt signaling pathway during the neoplastic progression of Barrett's esophagus
    Clement, G.
    Braunschweig, R.
    Pasquier, N.
    Bosman, F. T.
    Benhattar, J.
    [J]. ONCOGENE, 2006, 25 (21) : 3084 - 3092
  • [26] Abnormal expression and function of desmosomal cadherins in the neoplastic progression of Barrett's esophagus
    Morris, CD
    Tselepis, C
    Harrison, R
    Chidgey, MA
    Attwood, SA
    Garrod, D
    Jankowski, JA
    [J]. GASTROENTEROLOGY, 2001, 120 (05) : A412 - A412
  • [27] Novel in vitro model for studying the development and neoplastic progression of Barrett's esophagus
    Maniar, RR
    Ramirez, RD
    Morales, CP
    Dimitrijevich, SD
    Spechler, SJ
    Souza, RF
    [J]. GASTROENTEROLOGY, 2004, 126 (04) : A235 - A235
  • [28] Alterations of the Wnt signaling pathway during the neoplastic progression of Barrett's esophagus
    G Clément
    R Braunschweig
    N Pasquier
    F T Bosman
    J Benhattar
    [J]. Oncogene, 2006, 25 : 3084 - 3092
  • [29] Higher risk of neoplastic progression of Barrett's esophagus in patients with systemic sclerosis
    Anilkumar, Mythri
    Alkhayyat, Motasem
    Grewal, Udhayvir S.
    Sanaka, Madhusudhan R.
    Thota, Prashanthi N.
    [J]. GASTROENTEROLOGY REPORT, 2021, 9 (06): : 595 - 596
  • [30] Molecular Targets for Affinity Peptide Specific for Neoplastic Barrett's Esophagus
    Komarck, Chris M.
    Vivekanandan, Anuradha
    Pennathur, Subramaniam
    Wang, Thomas D.
    [J]. GASTROENTEROLOGY, 2009, 136 (05) : A646 - A646